By Michelle Llamas 
Big Pharma paid out big settlements and got hit with some big jury verdicts in 2015. The year’s hardest hit companies include Johnson & Johnson, Takeda, Wright Medical and Boston Scientific. Lawsuits against the companies alleged the drug and device makers made false...
By Michelle Llamas 
This past Friday Olympus Corp. announced that it would recall a controversial medical scope linked to deadly superbug infections and give the device a design overhaul, according to an FDA statement. The scope in question, the TJF-Q180V duodenoscope, is used about 700,000...
By Chris Elkins 
People who suffer traumatic injuries face a “life-threatening” risk for blood clots, but inferior vena cava (IVC) filters don’t give them a survival benefit, according to a new study. IVC filters are metal devices inserted into the vein of a person at risk for pulmonary...
By Michelle Llamas 
A Georgia jury handed Wright Medical an $11 million dollar loss in the first federal trial over its Conserve hip implant. The jury found Wright’s implant was defective, unreasonably dangerous and the manufacturer misrepresented the product’s safety. The trial began on Nov. 10...
By Chris Elkins 
Medical device manufacturer Boston Scientific recalled two cardiology devices after receiving reports of deadly fractures. The company sent letters to hospitals and health care facilities in October, voluntarily recalling 955 RotaWire Elite and wireClip Torquer devices. The...
By Michelle Llamas 
The number of Zofran birth defect lawsuits continues to climb after the U.S. Judicial Panel on Multidistrict Litigation issued the order to consolidate cases before Judge F. Dennis Saylor in Massachusetts. Parents of babies born with serious birth defects filed lawsuits against...
By Michelle Llamas 
A study published in the Journal of Arthroplasty found the Apex K2 hip implant manufactured by OMNI — formerly OMNIlife Science, Inc. — has an above average rate of wearing down and complications. Some may fail in as little as a year after being implanted. This news may be...
By Chris Elkins 
Danish manufacturer Coloplast increased the transvaginal mesh litigation provision in its budget by 3 billion Danish crowns ($448 million). The provision is set aside to cover settlement and legal costs in the U.S. More than 2,000 lawsuits against Coloplast are pending in a...
By Michelle Llamas 
Takeda Pharmaceuticals reached settlement agreements with two Nevada plaintiffs who say the company’s Type 2 diabetes drug Actos gave them bladder cancer. After more than a month of arguments and testimonies, the Japanese drugmaker reached confidential settlements with the two... Page 7 of 17
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.